Another Bayer, radium-223 (Xofigo) update

According to information on the Malecare Facebook page, Bayer is hoping to be able to re-start manufacturing of radium-223 at their plant in Norway at some time in November. However, no specific date has been provided for product availability, as yet.

Global Phase III trial of enzalutamide in progressive, high-risk prostate cancer

According to a joint media release from Medivation and Astellas earlier today, the companies will soon be initiating an important and major new trial of enzalutamide in men with progressive prostate cancer after first-line therapy. … READ MORE …

Long-term impact on workplace status after radical prostatectomy

A recent Norwegian study has concluded that pre-surgical counseling of men electing treatment for prostate cancer by radical prostatectomy needs to include advice about risk for the possibility of post-surgical issues that may affect work status and their working life 3 years after their surgery. … READ MORE …

Second-line therapy for progressive, high-risk prostate cancer: time for a STAMPEDE-like trial?

Let’s say you are 58 years of age, in apparently excellent health for your age, when you get diagnosed with high-risk prostate cancer, based on a Gleason score of 4 + 4 = 8, a PSA level of 3.7, and a clinical stage of T1c, with 4/12 biopsy cores positive for cancer. … READ MORE …

One more reason to cut out the cigarettes

Surgeons already don’t like to operate on smokers. They don’t do as well during and after surgery as non-smokers, not least because smokers can have problems with anesthesia. Now come data suggesting that smoking during radiation therapy is a pretty lousy idea too. … READ MORE …

Most “top-rated” web sites advocate shared decision-making about screening

Despite the recommendations of the USPSTF and others, “Only 17 percent of top-ranked consumer health websites advise against screening for prostate cancer” according to a paper just presented by researchers at the the 2014 Clinical Congress of the American College of Surgeons (ACS), currently ongoing in San Francisco. … READ MORE …

Can Google help to better diagnose cancer?

There’s a lot of hype today about a new initiative of the Google X research group, which has announced that it is investigating the use of nanoparticles to identify early signs of all sorts of disorders from fatty plaques that can cause a heart attack or stroke to early signs of cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,157 other followers